Trial Profile
A pilot study of STENTYS Drug-Eluting Stents in Patients with total occlusion of a coronary artery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2018
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Pharmacodynamics
- Acronyms SPACIOUS
- 31 Oct 2018 New trial record
- 25 Sep 2018 Final results will be available during TCT, as reported in an abstract presented at the 30th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
- 25 Sep 2018 Results presented at the 30th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics